OMER
OMER
NASDAQ · Pharmaceuticals

Omeros Corp

$11.05
+0.05 (+0.45%)
As of Mar 23, 2:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
179.53M
Net Income
39.25M
Gross Margin
60.8%
Profit Margin
21.9%
Rev Growth
-2.9%
D/E Ratio
0.71
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 60.8% 60.8% 60.8%
Operating Margin 18.7% 19.1% 21.7%
Profit Margin 21.9% 16.0% 18.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 179.53M 176.40M 195.82M
Gross Profit 109.14M 107.24M 119.05M
Operating Income 33.58M 33.68M 42.53M
Net Income 39.25M 28.13M 36.61M
Gross Margin 60.8% 60.8% 60.8%
Operating Margin 18.7% 19.1% 21.7%
Profit Margin 21.9% 16.0% 18.7%
Rev Growth -2.9% +12.2% +10.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 235.40M 230.21M 255.32M
Total Equity 332.20M 318.14M 344.37M
D/E Ratio 0.71 0.72 0.74
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 43.74M 50.64M 56.07M
Free Cash Flow 39.04M 39.72M 27.68M